• A Study Testing VX-407 in Patients with Autosomal Dominant Polycystic Kidney Disease Who Have Specific PKD1 Gene Changes

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study of ustekinumab, adalimumab, and baricitinib for patients with folliculitis decalvans that is difficult to treat

    Not yet recruiting

    2 1 1 1
    France
  • A study of pembrolizumab and lenvatinib for patients with high risk locally advanced cervical cancer after chemoradiotherapy and brachytherapy

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Testing rasburicase for preventing and treating kidney problems in adult patients with sepsis and high uric acid levels

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Ropivacaine and Dexamethasone Nerve Block for Patients with Acute Low Back Pain

    Not yet recruiting

    3 1 1
    Investigated diseases:
    France
  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    France
  • Comparing lenalidomide and methotrexate for patients with difficult-to-treat cutaneous lupus erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study comparing rocuronium dosing based on ideal versus real body weight for airway tube placement in patients with severe obesity

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Testing UCPVax vaccine with or without pembrolizumab and temozolomide in patients with unmethylated MGMT glioblastoma after initial treatment

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    France
  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

powered by